transporting vitamin B 12 to the cells. Congenital deficiency of TC I1 leads to severe impairment of hematopoietic, gastrointestinal and immunologic functions. We have studied TC I1 levels in patients with acquired immunodeficiency states due to chemotherapy with prednisone, azathiorpine and/or chlorambucil. Two different assays to determine the B 12 binding Capacity of unsaturated TC I1 were used.
Two groups of patients were investigated: 1. Autoimmune diseases (AID), lupus erythematodes 35, dermatomyositis 3, autoimmune hemolytic anemia 2; 2. Renal transplant patients 39 under immunosuppressive therapy.
Results: TC I1 was found normal or elevated 2-5 fold in Untreated AID, normal in AID under therapy in remission, increased 1.5-3 fold in treated, but active AID and normal or elevated 1.5 fold in treated renal transplant patients. Thus, immunosuppressive treatment reduces high TC I1 serum concentrations in AID to normal but not to subnormal levels ( roUP 1
One other report in the literature found equally (2-% fold) elevated TC I1 in acute leukemia and lymphoma, which decreased after therapy. These data and normal or elevated TC I1 found in group 2 indicate that synthesis of TC I1 is not restricted by immunosuppressive drugs. Vitamin 812 in blood is transported by specific carrier proteins, the transcobalamins (TC 1, 11 and 111). TC 11 is of particular interest since it carries and delivers vitamin B12 to the cells. Polyacrylamid gel electrophoresis was used to separate TC I and I11 from TC 11. This was achieved after saturation of TC I, I1 and I11 with 57 Co-labelled vitamin B12 and subsequent neuraminidase degradation of TC I and 111. Unchanged TC I1 could then be separated electrophoretically fron the other transcobalamin fractions. Autoradiographic evaluation showed that the TC I1 fraction is composed of several isoprotein bands (individual isoprotein patterns. probably genetically determined, were observed). Absolute radioactivity of the gel and relative intensities of the radioactive bar.ds were used to quantitate the TC 11 fraction. unsaturated TC 11 levels were also determined using a new immunochemical method, based on the precipitation of TC I1 by insolubilised anti-TC I1 antiserum (radio immunosorbent technique = RIST). The results of TC I1 determinations with these two basically different assays correlate satisfactorily. 'Iaunersohen lLinderspital Rabbit antisera against the corvon Porms of childhood acute lymphoblastic leukemia (ALL) the 0-and T-ALL were produced. Extensive absorptions of the antisera removed the crossreactions with normal mature lymphocyte populations and bone mmror progenitor cells. 1) A characterization of the tyffof ALL by use of the highly purified antisera is possible by different test systems such as cytotoxiciry, immunfluorescence and quantitative complement fixation. The results show that the former test systems such as rosette technique failled to identify some 0-ALL. Therefore by use of specific antisera the benefit of chemotherapeutic treatment for the different forms of ALL can be better calculated. 2 ) Treatment of a patient with 0-ALL during hls 3rd bone narrow relapse by h i : h doses of APti-O-ALL globulin revealed a ~arked deorease in circulating blast cells bul; no effect on bone marrow blast cells. Our approach aims for an elimination of residual leucemic cells in bone marrow durin: haemopoietic remission usins the cytotoxic effect of the antisera. The use of A-0-ALL-G for "antileukemi0 autotransplantation" is proposed. In attempt to further differentiate cytochemically and immunologically defined subtypes of ALL AcP isoenzpe patterns of various cell extracts were investigated by isoelectric focusing in gels. Isoenzyme patterns of T-ALL blasts were found to be identical to that of normal and fetal thymus cells. Also one case of BURKITT lymphoma, investigated so far, did not show any significant difference of AcP isoenzpes to T-ALL. The so called Nan T-Non B-.ALL however turned out to be a heterogenous group with different cytochemical and isoenzymic AcP patterns: cytochemically undifferentiated cells either contained only one single band of AcP or no AcP was detec- As indicative of the iron status during the early anemia of prematurity, transfcrrin, iron, and ferritin levels of plasma were followed in infants with birth weight less than 1500 g. Ceruloplasmin, thought to act as ferroxidase, was also studied. Oral iron therapy was started at the age of four weeks.
USE OF SPECIFIC 'GT1SE.U A M N S T LETiIIA-ASSOCLITED AVTIGENS
Transferrin concentration rose steadily from a mean value of 1.58 g/l at 1 week of age to 2.17 g/l at 8 weeks of age.
Plasma iron concentration at 1 week of age was 15.6 + 5.5 umol/~ and did not change significantly during the 8 week period. Ferritin in cord blood of full term infants was w a i n the range of normal adult males, while the levels in cord blood from 10 infants with birth weight less than 2000 g were lower. Ferritin levels during the course of the early anemia will be discussed. Cemloplasmin showed a more variable course than transferrin, but after 4 weeks a progressive rise occured. Mean value at 1 week of age was 0.11 g/l, at 6 weeks 0.13 g/l, and 0.15 g/l at 8 weeks.
The plasma iron levels observed are within the normal range for full term infants. However, whether they provide suffient available iron for the accelerated erythropoiesis of this period is unclear. The progressive rise in transferrin suggests that in this period the level more reflects the increase in general protein synthesizing capacity than the iron status. Ferritin concentration, on the orher hand, seems to reflect iron stores.
